These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

662 related articles for article (PubMed ID: 28069527)

  • 41. Hepatocellular carcinoma recurrence among liver transplant recipients within the Milan criteria.
    Felga G; Evangelista AS; Salvalaggio PR; Curvelo LA; Della Guardia B; Almeida MD; Afonso RC; Ferraz-Neto BH
    Transplant Proc; 2012 Oct; 44(8):2459-61. PubMed ID: 23026620
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Outcomes of loco-regional therapy for down-staging of hepatocellular carcinoma prior to liver transplantation.
    Shi XJ; Jin X; Wang MQ; Wei LX; Ye HY; Liang YR; Luo Y; Dong JH
    Hepatobiliary Pancreat Dis Int; 2011 Apr; 10(2):143-50. PubMed ID: 21459720
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Pilot study of living donor liver transplantation for patients with hepatocellular carcinoma exceeding Milan Criteria (Barcelona Clinic Liver Cancer extended criteria).
    Llovet JM; Pavel M; Rimola J; Diaz MA; Colmenero J; Saavedra-Perez D; Fondevila C; Ayuso C; Fuster J; Ginès P; Bruix J; Garcia-Valdecasas JC
    Liver Transpl; 2018 Mar; 24(3):369-379. PubMed ID: 29140601
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Patient and tumour biology predict survival beyond the Milan criteria in liver transplantation for hepatocellular carcinoma.
    Andreou A; Gül S; Pascher A; Schöning W; Al-Abadi H; Bahra M; Klein F; Denecke T; Strücker B; Puhl G; Pratschke J; Seehofer D
    HPB (Oxford); 2015 Feb; 17(2):168-75. PubMed ID: 25263399
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A single-center retrospective analysis of liver transplantation on 255 patients with hepatocellular carcinoma.
    Wang ZX; Song SH; Teng F; Wang GH; Guo WY; Shi XM; Ma J; Wu YM; Ding GS; Fu ZR
    Clin Transplant; 2010; 24(6):752-7. PubMed ID: 20030683
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Follow-up Imaging After Liver Transplantation Should Take Into Consideration Primary Hepatocellular Carcinoma Characteristics.
    Dioguardi Burgio M; Ronot M; Fuks D; Dondero F; Cauchy F; Gaujoux S; Dokmak S; Paradis V; Durand F; Belghiti J; Vilgrain V
    Transplantation; 2015 Aug; 99(8):1613-8. PubMed ID: 25710611
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Downstaging prior to liver transplantation for hepatocellular carcinoma: advisable but at the price of an increased risk of cancer recurrence - a retrospective study.
    Toso C; Meeberg G; Andres A; Shore C; Saunders C; Bigam DL; Shapiro AMJ; Compagnon P; Berney T; Majno P; Kneteman N
    Transpl Int; 2019 Feb; 32(2):163-172. PubMed ID: 30152891
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Validation of the AFP model as a predictor of HCC recurrence in patients with viral hepatitis-related cirrhosis who had received a liver transplant for HCC.
    Notarpaolo A; Layese R; Magistri P; Gambato M; Colledan M; Magini G; Miglioresi L; Vitale A; Vennarecci G; Ambrosio CD; Burra P; Di Benedetto F; Fagiuoli S; Colasanti M; Maria Ettorre G; Andreoli A; Cillo U; Laurent A; Katsahian S; Audureau E; Roudot-Thoraval F; Duvoux C
    J Hepatol; 2017 Mar; 66(3):552-559. PubMed ID: 27899297
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Predictive factors for extrahepatic recurrence of hepatocellular carcinoma following liver transplantation.
    Andreou A; Bahra M; Schmelzle M; Öllinger R; Sucher R; Sauer IM; Guel-Klein S; Struecker B; Eurich D; Klein F; Pascher A; Pratschke J; Seehofer D
    Clin Transplant; 2016 Jul; 30(7):819-27. PubMed ID: 27107252
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Survival Benefit of Liver Transplantation Versus Resection for Hepatocellular Carcinoma: Impact of MELD Score.
    Vitale A; Huo TL; Cucchetti A; Lee YH; Volk M; Frigo AC; Cescon M; Tuci F; Pinna AD; Cillo U
    Ann Surg Oncol; 2015; 22(6):1901-7. PubMed ID: 25234023
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Hangzhou criteria as downstaging criteria in hepatocellular carcinoma before liver transplantation: A multicenter study from China.
    Zhan QF; Ling SB; Deng YN; Shan QN; Ye QW; Xu SJ; Jiang GJ; Lu D; Wei XY; Zhuang L; Zhang W; Shen T; Cen BN; Xie HY; Liu JM; Wu J; Zheng SS; Yang Y; Xu X
    Hepatobiliary Pancreat Dis Int; 2020 Aug; 19(4):349-357. PubMed ID: 32622826
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Yttrium-90 radioembolization as a bridge to liver transplantation: a single-institution experience.
    Tohme S; Sukato D; Chen HW; Amesur N; Zajko AB; Humar A; Geller DA; Marsh JW; Tsung A
    J Vasc Interv Radiol; 2013 Nov; 24(11):1632-8. PubMed ID: 24160821
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Liver transplantation for hepatocellular carcinoma in patients beyond the Milan but within the UCSF criteria.
    Sotiropoulos GC; Molmenti EP; Omar OS; Bockhorn M; Brokalaki EI; Lang H; Frilling A; Broelsch CE; Malagó M
    Eur J Med Res; 2006 Nov; 11(11):467-70. PubMed ID: 17182358
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Bridging and downstaging treatments for hepatocellular carcinoma in patients on the waiting list for liver transplantation.
    Pompili M; Francica G; Ponziani FR; Iezzi R; Avolio AW
    World J Gastroenterol; 2013 Nov; 19(43):7515-30. PubMed ID: 24282343
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Downstaging Outcomes for Hepatocellular Carcinoma: Results From the Multicenter Evaluation of Reduction in Tumor Size before Liver Transplantation (MERITS-LT) Consortium.
    Mehta N; Frenette C; Tabrizian P; Hoteit M; Guy J; Parikh N; Ghaziani TT; Dhanasekaran R; Dodge JL; Natarajan B; Holzner ML; Frankul L; Chan W; Fobar A; Florman S; Yao FY
    Gastroenterology; 2021 Nov; 161(5):1502-1512. PubMed ID: 34331914
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Liver transplantation outcomes for early-stage hepatocellular carcinoma: results of a multicenter study.
    Leung JY; Zhu AX; Gordon FD; Pratt DS; Mithoefer A; Garrigan K; Terella A; Hertl M; Cosimi AB; Chung RT
    Liver Transpl; 2004 Nov; 10(11):1343-54. PubMed ID: 15497158
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Liver resection for transplantable hepatocellular carcinoma: long-term survival and role of secondary liver transplantation.
    Cherqui D; Laurent A; Mocellin N; Tayar C; Luciani A; Van Nhieu JT; Decaens T; Hurtova M; Memeo R; Mallat A; Duvoux C
    Ann Surg; 2009 Nov; 250(5):738-46. PubMed ID: 19801927
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A novel prognostic nomogram accurately predicts hepatocellular carcinoma recurrence after liver transplantation: analysis of 865 consecutive liver transplant recipients.
    Agopian VG; Harlander-Locke M; Zarrinpar A; Kaldas FM; Farmer DG; Yersiz H; Finn RS; Tong M; Hiatt JR; Busuttil RW
    J Am Coll Surg; 2015 Apr; 220(4):416-27. PubMed ID: 25690672
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Outcomes of Liver Transplantation for Hepatocellular Carcinoma Beyond the University of California San Francisco Criteria: A Single-center Experience.
    Victor DW; Monsour HP; Boktour M; Lunsford K; Balogh J; Graviss EA; Nguyen DT; McFadden R; Divatia MK; Heyne K; Ankoma-Sey V; Egwim C; Galati J; Duchini A; Saharia A; Mobley C; Gaber AO; Ghobrial RM
    Transplantation; 2020 Jan; 104(1):113-121. PubMed ID: 31233480
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Outcome of liver transplantation for hepatocellular carcinoma -- a single center experience.
    Iacob R; Iacob S; Gheorghe L; Gheorghe C; Hrehoreţ D; Brașoveanu V; Croitoru A; Herlea V; Popescu I
    Chirurgia (Bucur); 2013; 108(4):446-50. PubMed ID: 23958083
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 34.